Patents by Inventor Ulrich Benz

Ulrich Benz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230069783
    Abstract: The present invention relates to a method for separating poly-isoprene and/or other apolar valuable substances from vegetable feedstock, with a first pretreatment (100) of the vegetable feedstock; a percussive, cutting and/or rubbing mechanical processing (102) of the vegetable feedstock after the pre-treatment in a wet phase, during which the polyisoprene and/or other apolar valuable substances contained in the processed raw plant materials are extracted from the vegetable feedstock; and after the mechanical processing (102), a separation (104) of the polyisoprene and/or the other apolar valuable substances from the wet phase. The invention proposes that, before or during the mechanical processing (102) in the wet phase, an adsorber material (106) be added to the ground product mixture to create a method which makes it possible to obtain polyisoprene and other apolar valuable substances from plants having a low rubber content in a technically simpler manner.
    Type: Application
    Filed: December 8, 2020
    Publication date: March 2, 2023
    Inventors: Henning Zoz, Hans Ulrich Benz, Boje Müller, Dirk Prüfer, Christian Schulze Gronover, Vincent Benninghaus, Janina Epping
  • Patent number: 8660905
    Abstract: A method and system are described for validating process models. A process semantic model including a semantic directed graph including nodes associated with tasks and edges associated with a direction of flow of execution of the tasks may be obtained. Edges entering nodes include annotations including precondition semantic indicators associated with the entering edges and edges exiting nodes include annotations including postcondition semantic indicators associated with the exiting edges. The process semantic model may be traversed to determine a flow of execution of activities associated with the tasks based on visiting the nodes based on a depth-first traversal. A validity of execution associated with a flow of execution of the activities associated with the tasks may be determined based on checking a validity of execution status based on a semantic processing of one or more semantic annotation indicators associated with the precondition semantic indicators and the postcondition semantic indicators.
    Type: Grant
    Filed: October 31, 2007
    Date of Patent: February 25, 2014
    Assignee: SAP AG
    Inventors: Ingo Weber, Ulrich Benz
  • Publication number: 20090113394
    Abstract: A method and system are described for validating process models. A process semantic model including a semantic directed graph including nodes associated with tasks and edges associated with a direction of flow of execution of the tasks may be obtained. Edges entering nodes include annotations including precondition semantic indicators associated with the entering edges and edges exiting nodes include annotations including postcondition semantic indicators associated with the exiting edges. The process semantic model may be traversed to determine a flow of execution of activities associated with the tasks based on visiting the nodes based on a depth-first traversal. A validity of execution associated with a flow of execution of the activities associated with the tasks may be determined based on checking a validity of execution status based on a semantic processing of one or more semantic annotation indicators associated with the precondition semantic indicators and the postcondition semantic indicators.
    Type: Application
    Filed: October 31, 2007
    Publication date: April 30, 2009
    Applicant: SAP AG
    Inventors: Ingo Weber, Ulrich Benz
  • Patent number: 5585392
    Abstract: The method of treating stroke in a patient suffering therefrom by administering a substituted aminomethylchroman of the formula ##STR1## in which Z--denotes a group of the formula ##STR2## R.sup.1, E and F can be hydrogen or other radicals, or salts thereof.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: December 17, 1996
    Assignee: Bayer Aktiengesellschaft
    Inventors: Bodo Junge, Rudolf Schohe, Peter-Rudolf Seidel, Thomas Glaser, J org Traber, Ulrich Benz, Teunis Schuurman, Jean-Marie Viktor De Vry
  • Patent number: 5506246
    Abstract: A method of treating depression or stroke in a patient suffering therefrom by administering a substituted aminomethylchroman of the formula ##STR1## in which Z--denotes a group of the formula ##STR2## and R.sup.1, E and F can be hydrogen or other radicals, or salts thereof.
    Type: Grant
    Filed: December 21, 1993
    Date of Patent: April 9, 1996
    Assignee: Bayer Aktiengesellschaft
    Inventors: Bodo Junge, Rudolf Schohe, Peter-Rudolf Seidel, Thomas Glaser, Jorg Traber, Ulrich Benz, Teunis Schuurman, Jean-Marie V. De Vry
  • Patent number: 5300523
    Abstract: For binding 5-HT.sub.
    Type: Grant
    Filed: April 7, 1992
    Date of Patent: April 5, 1994
    Assignee: Bayer Aktiengesellschaft
    Inventors: Bodo Junge, Rudolf Schohe, Peter-Rudolf Seidel, Thomas Glaser, Jorg Traber, Ulrich Benz, Teunis Schuurman, Jean-Marie Viktor De Vry
  • Patent number: 5137901
    Abstract: For binding 5-HT.sub.1 receptors and thereby treating central nervous system disorders, novel substituted aminomethyltetralins and their heterocyclic analogues of the formula ##STR1## in which Z--denotes a group of the formula ##STR2## R.sup.1, E and F can be hydrogen or other radicals, or salts thereof.
    Type: Grant
    Filed: September 26, 1989
    Date of Patent: August 11, 1992
    Assignee: Bayer Aktiengesellschaft
    Inventors: Bodo Junge, Rudolf Schohe, Peter-Rudolf Seidel, Thomas Glaser, Jorg Traber, Ulrich Benz, Teunis Schuurman, Jean-Marie V. De Vry
  • Patent number: 4879390
    Abstract: Purified Clausenamide of the formula ##STR1## is obtained by extraction of leaves of Clausena lansium followed by purification, Reduction products, ethers, etc. can be produced. The compounds are effective in treating hypoxia and amnesia.
    Type: Grant
    Filed: April 27, 1988
    Date of Patent: November 7, 1989
    Assignees: Chinese Academy of Medical Sciences, Bayer Aktiengesellschaft
    Inventors: Yen-rong Chen, Ming-he Yang, Liang Huang, Geng-tao Liu, Ulrich Benz
  • Patent number: 4705794
    Abstract: Pyridinecarboxylic acid esters of the formula ##STR1## in which R is an optionally substituted aryl or heterocyclic radical,R.sup.1 and R.sup.2 are hydrogen, alkyl, aryl, aralkyl, acyloxyalkyl or hydroxyalkyl, or R.sup.1 with X forms a carbonyl-containing heterocyclic ring,X is --CN, --CO--R.sup.4, --COOR.sup.5 or --SO.sub.2 R.sup.6,R.sup.4, R.sup.5 and R.sup.6 are various optionally substituted radicals, andR.sup.3 is different from R.sup.5 and is a substituted or interrupted hydrocarbon radical,or pharmaceutically acceptable salts thereof control the otherwise negative effects of ischaemia and/or hypoxia.
    Type: Grant
    Filed: February 28, 1983
    Date of Patent: November 10, 1987
    Assignee: Bayer Aktiengesellschaft
    Inventors: Egbert Wehinger, Horst Meyer, Ulrich Benz
  • Patent number: 4563458
    Abstract: The invention relates to substituted 4-aminomethylene-chromans and chromens of Formula (I) infra, as well as methods for making of said chromans and chromens, compositions containing said chromans and chromens and methods for the use of said chromans, chromens and compositions containing said chromans and chromens. The compounds and compositions of the invention are useful for their circulation influencing activity.
    Type: Grant
    Filed: December 13, 1983
    Date of Patent: January 7, 1986
    Assignee: Bayer Aktiengesellschaft
    Inventors: Arno Widdig, Hans-Joachim Kabbe, Andreas Knorr, Ulrich Benz
  • Patent number: 4497821
    Abstract: A method of controlling damage to the central nervous system of a patient which comprises administering to such patient a central nervous system-controlling effective amount of a pyridine derivative of the formula ##STR1## in which R is an optionally substituted aryl or heterocyclic radical,R.sup.1 and R.sup.2 are hydrogen or various organic radicals,X and Y are CN, --CO--R.sup.3, --COOR.sup.4 or --SO.sub.2 R.sup.5, or form with R.sup.1 or R.sup.2 a carbonyl-containing ring,R.sup.3 is an alkyl, aryl or aralkyl radical,R.sup.4 is hydrogen or an organic radical, andR.sup.5 is an optionally substituted alkyl or phenyl radical,or a salt thereof.
    Type: Grant
    Filed: February 28, 1983
    Date of Patent: February 5, 1985
    Assignee: Bayer Aktiengesellschaft
    Inventors: Egbert Wehinger, Horst Meyer, Ulrich Benz